Good morning :)
Switch to
Place Order

Krebs Biochemicals and Industries Ltd

KREBSBIO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹366 cr, stock is ranked 1,332
High RiskStock is 4.56x as volatile as Nifty
169.804.30 (+2.60%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹366 cr, stock is ranked 1,332
High RiskStock is 4.56x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-12.91
PB RatioPB Ratio
-28.76
Dividend YieldDiv. Yield
Sector PESector PE
38.07
Sector PBSector PB
5.10
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

201820192020202134.1348.2033.7854.32-17.83-20.01-28.87-28.35
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 2.71%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Shareholders meeting 
Announced OnNov 30, 2021

Krebs Biochemicals and Industries Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on November 29, 2021. Further, the company has informed the Exchange regarding voting results. | Download

Krebs Biochemicals and Industries Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on November 29, 2021. Further, the company has informed the Exchange regarding voting results. | Download

Shareholders meeting 
Announced OnNov 29, 2021

Krebs Biochemicals and Industries Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on November 29, 2021.Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed the summary of proceedings of the Extra Ordinary General Meeting (EGM) of the Company held on Monday, November 29 2021 through Video Conference / Other Audio-Visual Means.Further Mrs. Krithika Sharma, Practicing Company Secretary is the Scrutinizer for the remote e- voting and voting process carried out at the EGM.The voting results on the resolutions shall be declared on or before 1st December, 2021, along with scrutinizer s report and the same shall be placed on the Company s website at www.krebsbiochem.com and on the website of Kfintech Technologies Private Limited at www.kfintech.com and shall also be communicated to the Stock Exchanges where the shares of the Company are listed. | Download

Krebs Biochemicals and Industries Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on November 29, 2021.Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed the summary of proceedings of the Extra Ordinary General Meeting (EGM) of the Company held on Monday, November 29 2021 through Video Conference / Other Audio-Visual Means.Further Mrs. Krithika Sharma, Practicing Company Secretary is the Scrutinizer for the remote e- voting and voting process carried out at the EGM.The voting results on the resolutions shall be declared on or before 1st December, 2021, along with scrutinizer s report and the same shall be placed on the Company s website at www.krebsbiochem.com and on the website of Kfintech Technologies Private Limited at www.kfintech.com and shall also be communicated to the Stock Exchanges where the shares of the Company are listed. | Download

Reply to Clarification Sought 
Announced OnNov 22, 2021

KREBSBIO: The Exchange had sought clarification from Krebs Biochemicals and Industries Limited with respect to announcement dated 30-Jul-2021, regarding board meeting held on July 30, 2021. On basis of above the Company was required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director); 2. Provide confirmation in compliance with SEBI Letter dated June 14, 2018 read alongwith NSE Circular dated June 20, 2018.ᅡᅠThe response of the Company is attached. | Download

KREBSBIO: The Exchange had sought clarification from Krebs Biochemicals and Industries Limited with respect to announcement dated 30-Jul-2021, regarding board meeting held on July 30, 2021. On basis of above the Company was required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director); 2. Provide confirmation in compliance with SEBI Letter dated June 14, 2018 read alongwith NSE Circular dated June 20, 2018.ᅡᅠThe response of the Company is attached. | Download

See all events